Tini Figueroa

Tini Figueroa has a diverse work experience that spans both legal and ad operations roles. Tini started their career as a Paralegal at Baker & McKenzie Buenos Aires in 2013 and later worked as a Relatora Vocalia at Tribunal Fiscal de la Nación from 2015 to 2017. In 2017, they joined Grupo Rio Varadero as an Abogada in the legal department.

In 2018, Tini decided to pivot their career and entered the world of ad tech startups. Tini joined Herolens (Part of Innovid) as a Customer Support Manager and later became the Manager of Customer Success. During their time at Herolens, they focused on campaign traffic and platform usage, contributing to process standardization and documentation creation.

In 2019, Tini participated in the merger of Herolens and Innovid, where they became an Ad Operations Coordinator. Tini learned to use the Innovid platform and contributed to process improvement and documentation in a unified way.

In 2020, Tini was promoted to the role of Sr Ad Operations Manager at Innovid. Tini led and developed a training program on traffic DCO campaigns for Innovid's US Adops Team and vendors, using Kahoot to ensure its effectiveness. Tini also provided support to team members across the company in successfully trafficking their DCO campaigns.

During their maternity leave in 2021, Tini was offered the opportunity to lead a trafficking team upon their return, becoming the Ad Operations Team Lead. Tini led their direct reports and new joiners of the Adops team during their first three months in the company, and this experience showed their the combination of maternity and professional growth.

Most recently, in 2022, Tini was promoted to the position of Associate Director, Ad Operations at Innovid, where they currently work. The summary showcases Tini's growth and adaptability in both legal and ad operations fields.

Tini Figueroa attended the University of Buenos Aires from 2011 to 2016, where they obtained a degree in law. In 2017, they enrolled at Scalabl Academy to pursue a degree in academia Scalbl, but the specific field of study is not mentioned.